Aoki M, Volkmann I, Tjernberg LO, Winblad B, Bogdanovic N (2008) Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer’s brain. NeuroReport 19:1085–1089. https://doi.org/10.1097/WNR.0b013e328302c858

Article  CAS  PubMed  Google Scholar 

Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631–639. https://doi.org/10.1212/wnl.42.3.631

Article  CAS  PubMed  Google Scholar 

Baerends E, Soud K, Folke J, Pedersen AK, Henmar S, Konrad L et al (2022) Modeling the early stages of Alzheimer’s disease by administering intracerebroventricular injections of human native Aβ oligomers to rats. Acta Neuropathol Commun 10:113. https://doi.org/10.1186/s40478-022-01417-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beckman D, Ott S, Donis-Cox K, Janssen WG, Bliss-Moreau E, Rudebeck PH et al (2019) Oligomeric Aβ in the monkey brain impacts synaptic integrity and induces accelerated cortical aging. Proc Natl Acad Sci USA 116:26239–26246. https://doi.org/10.1073/pnas.1902301116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ben-Nejma IRH, Keliris AJ, Daans J, Ponsaerts P, Verhoye M, Van der Linden A et al (2019) Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis. Acta Neuropathol Commun 7:180. https://doi.org/10.1186/s40478-019-0810-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M et al (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 27:3650–3662. https://doi.org/10.1523/jneurosci.0587-07.2007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R et al (2012) Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol 69:1002–1010. https://doi.org/10.1001/archneurol.2012.90

Article  PubMed  Google Scholar 

Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M et al (2007) Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol 171:2012–2020. https://doi.org/10.2353/ajpath.2007.070403

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolós M, Pallas-Bazarra N, Terreros-Roncal J, Perea JR, Jurado-Arjona J, Ávila J et al (2017) Soluble Tau has devastating effects on the structural plasticity of hippocampal granule neurons. Transl Psychiatry 7:1267. https://doi.org/10.1038/s41398-017-0013-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–278; discussion 278–284. doi:https://doi.org/10.1016/0197-4580(95)00021-6

Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

Article  PubMed  Google Scholar 

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404. https://doi.org/10.1007/s00401-006-0127-z

Article  PubMed  PubMed Central  Google Scholar 

Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969. https://doi.org/10.1097/NEN.0b013e318232a379

Article  CAS  PubMed  Google Scholar 

Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B et al (2012) Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 109:8740–8745. https://doi.org/10.1073/pnas.1206171109

Article  PubMed  PubMed Central  Google Scholar 

Ciccone R, Franco C, Piccialli I, Boscia F, Casamassa A, de Rosa V et al (2019) Amyloid β-induced upregulation of Na(v)1.6 underlies neuronal hyperactivity in Tg2576 Alzheimer’s disease mouse model. Sci Rep 9:13592. https://doi.org/10.1038/s41598-019-50018-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–913. https://doi.org/10.1038/ncb1901

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collins-Praino LE, Francis YI, Griffith EY, Wiegman AF, Urbach J, Lawton A et al (2014) Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity. Acta Neuropathol Commun 2:83. https://doi.org/10.1186/s40478-014-0083-0

Article  PubMed  PubMed Central  Google Scholar 

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755–766. https://doi.org/10.1007/s00401-014-1349-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, Salloway S (2021) Aducanumab produced a clinically meaningful benefit in association with amyloid lowering. Alzheimers Res Ther 13:98. https://doi.org/10.1186/s13195-021-00838-z

Article  PubMed  PubMed Central  Google Scholar 

De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN et al (2008) Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging 29:1334–1347. https://doi.org/10.1016/j.neurobiolaging.2007.02.029

Article  CAS  PubMed  Google Scholar 

DeVos SL, Corjuc BT, Oakley DH, Nobuhara CK, Bannon RN, Chase A et al (2018) Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer’s Disease Brain. Front Neurosci 12:267. https://doi.org/10.3389/fnins.2018.00267

Article  PubMed  PubMed Central  Google Scholar 

Fein JA, Sokolow S, Miller CA, Vinters HV, Yang F, Cole GM et al (2008) Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer’s Disease Synaptosomes. Am J Pathol 172:1683–1692. https://doi.org/10.2353/ajpath.2008.070829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F et al (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15–20. https://doi.org/10.1016/s0002-9440(10)64700-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guillozet AL, Weintraub S, Mash DC, Mesulam MM (2003) Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 60:729–736. https://doi.org/10.1001/archneur.60.5.729

Article  PubMed  Google Scholar 

Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B et al (2016) Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice. J Exp Med 213:2635–2654. https://doi.org/10.1084/jem.20160833

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185. https://doi.org/10.1126/science.1566067

Article  CAS  PubMed  Google Scholar 

Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356. https://doi.org/10.1126/science.1072994

Article  CAS  PubMed  Google Scholar 

Héraud C, Goufak D, Ando K, Leroy K, Suain V, Yilmaz Z et al (2014) Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice. Neurobiol Dis 62:100–112. https://doi.org/10.1016/j.nbd.2013.09.010

Article  CAS  PubMed  Google Scholar 

Hojjati SH, Chiang GC, Butler TA, Leon MD, Gupta A, Li Y, Sabuncu MR, Feiz F, Nayak S, Shteingart J et al (2023) Disentangling the distal association between β-Amyloid and tau pathology at varying stages of tau deposition. medRxiv: 2023.2003.2031.23288013. doi:https://doi.org/10.1101/2023.03.31.23288013

Horie K, Barthélemy NR, Mallipeddi N, Li Y, Franklin EE, Perrin RJ et al (2020) Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain. Acta Neuropathol Commun 8:149. https://doi.org/10.1186/s40478-020-01019-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimer’s Dement 8:1–13. https://doi.org/10.1016/j.jalz.2011.10.007

Article  Google Scholar 

Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer’s-like tauopathy. J Neurosci 33:1024–1037. https://doi.org/10.1523/jneurosci.2642-12.2013